Scherm­afbeelding 2024 07 02 om 09.45.49

Cystatin C FS

Gold standard for early kidney disease diagnosis

Scherm­afbeelding 2024 07 02 om 09.38.51

EUROIMMUN | EASY. EFFICIENT. EXCEPTIONAL

Scherm­afbeelding 2024 07 02 om 09.26.46

New Generation Hospital Glucose/Ketone Meter

Only glucose meter FDA-cleared for use with critically ill patients

Scherm­afbeelding 2024 07 02 om 08.57.03

Novel DNA-based method revolutionises sepsis diagnosis

Researchers from Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and partners have developed a groundbreaking approach to identify pathogens in sepsis patients, potentially reducing mortality rates and improving treatment outcomes. The team has been awarded the 2024 Stifterverband Science Prize for their innovative work.

Withaferin A

Scalable synthesis of withanolides: A significant development in cancer research

Researchers at Moffitt Cancer Center have developed a novel method for the scalable synthesis of withanolides, a class of naturally occurring compounds with significant potential in cancer treatment. This groundbreaking approach, published in Science Advances [1], could revolutionise cancer research by providing a reliable and efficient means of producing these vital compounds in large quantities.

Yang Changhuei FPM APIC

Beyond FPM: New imaging technique promises clearer, faster microscopy

A team of engineers at the California Institute of Technology (Caltech) has developed a groundbreaking microscopy method that promises to revolutionise biomedical imaging, digital pathology, and drug screening. The new technique, called Angular Ptychographic Imaging with Closed-form method (APIC), builds upon and surpasses the capabilities of its predecessor, Fourier ptychographic microscopy (FPM).

Cyclosporine 3D

Breakthrough in cyclic peptide synthesis could accelerate antibiotic development

Scientists at King’s College London have developed a rapid method for creating cyclic peptides, potentially accelerating the production of new antibiotics to combat antimicrobial resistance (AMR). The research, published in the Journal of the American Chemical Society [1], demonstrates a technique that reduces synthesis time from hours or days to mere minutes.

Takara Bio Europe Logo

New enzyme promises safer, more cost-effective mRNA synthesis

Takara Bio has unveiled a novel enzyme designed to enhance the safety and efficiency of mRNA production for therapeutic applications. The PrimeCap™ T7 RNA Polymerase (low dsRNA) addresses two significant challenges in mRNA synthesis: reducing immunogenic double-stranded RNA (dsRNA) and lowering the cost of capping.

Gyrolab Anti AAV kit

Gyros Protein Technologies launches innovative kit for detecting anti-AAV antibodies

Gyros Protein Technologies AB has introduced a new kit designed to streamline the detection of pre-existing antibodies against adeno-associated virus (AAV) vectors. The Gyrolab Generic Anti-Adeno Associated Virus (AAV) Kit aims to facilitate qualitative assessment of binding antibodies in both pre-clinical and clinical settings, supporting the development of AAV-based gene therapies.